Lilly CEO sees weight-loss drugs reaching about half of potential users at peak [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
who could benefit from them due to complexities of healthcare systems ?and financial constraints, Eli Lilly CEO David Ricks said at a conference on Friday. Lilly and rival ?Novo Nordisk have been competing for share in the global market for wildly popular GLP-1 injectable and oral weight-loss drugs, which analysts ?see topping $100 billion per year in the next decade. Today, just 1 in 10 people who are overweight or obese are using GLP-1s, Ricks said at the Semafor World Economy conference in Washington. "It's never going to be a hundred," he said. "For institutional reasons in healthcare and some other complexities in managing health, it's never going to be that high." Ricks ?pointed to low-cost statins, the most ?commonly prescribed cholesterol medicines, as a comparable example. "Between 40 and 50% of people who should be on them, are on them. I think of that as maybe a ceiling," ?he said. Lilly's just-launched weight-loss pill Foundayo was prescribed 1,390 times in the U
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Better Long-Term Buy: Eli Lilly or Viking Therapeutics? [Yahoo! Finance]Yahoo! Finance
- Is This the Biggest Game-Changer in Lilly's 150-Year History? [Yahoo! Finance]Yahoo! Finance
- Is This the Biggest Game-Changer in Lilly's 150-Year History? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Lilly weight-loss pill Foundayo shows strong first-week demand [USA TODAY]USA TODAY
- Lilly confirms date and conference call for first-quarter 2026 financial results announcement [TheStreet.com]TheStreet.com
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form DEFA14A
- 3/20/26 - Form DEF
- LLY's page on the SEC website